Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Stan Berenshteyn is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/29/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/28/2025 | GDRX | Buy Now | GoodRx Holdings | $4.41 | 81.36% | Stan Berenshteyn42% | $9 → $8 | Maintains | Overweight | Get Alert |
| 02/26/2025 | HQY | Buy Now | HealthEquity | $86.96 | 43.74% | Stan Berenshteyn42% | $110 → $125 | Maintains | Overweight | Get Alert |
| 02/07/2025 | DOCS | Buy Now | Doximity | $58.09 | -5.32% | Stan Berenshteyn42% | $43 → $55 | Maintains | Equal-Weight | Get Alert |
| 01/21/2025 | HCAT | Buy Now | Health Catalyst | $4.55 | 119.78% | Stan Berenshteyn42% | $13 → $10 | Maintains | Overweight | Get Alert |
| 01/13/2025 | OMCL | Buy Now | Omnicell | $35.01 | 14.25% | Stan Berenshteyn42% | $49 → $40 | Maintains | Equal-Weight | Get Alert |
| 01/13/2025 | DOCS | Buy Now | Doximity | $58.09 | -25.98% | Stan Berenshteyn42% | $41 → $43 | Maintains | Equal-Weight | Get Alert |
| 01/13/2025 | AMWL | Buy Now | American Well | $7.82 | 91.82% | Stan Berenshteyn42% | $15 → $15 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/06/2024 | VEEV | Buy Now | Veeva Systems | $234.21 | 21.69% | Stan Berenshteyn42% | $275 → $285 | Maintains | Overweight | Get Alert |
| 11/08/2024 | DOCS | Buy Now | Doximity | $58.09 | -29.42% | Stan Berenshteyn42% | $19 → $41 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/14/2024 | OMCL | Buy Now | Omnicell | $35.01 | 17.11% | Stan Berenshteyn42% | $30 → $41 | Maintains | Equal-Weight | Get Alert |
| 10/11/2024 | ACCD | Buy Now | Accolade | $6.99 | -14.16% | Stan Berenshteyn42% | $7 → $6 | Maintains | Equal-Weight | Get Alert |
| 08/06/2024 | AMWL | Buy Now | American Well | $7.82 | 91.82% | Stan Berenshteyn42% | $40 → $15 | Maintains | Equal-Weight | Get Alert |
| 08/02/2024 | OMCL | Buy Now | Omnicell | $35.01 | -14.31% | Stan Berenshteyn42% | $26 → $30 | Maintains | Equal-Weight | Get Alert |
| 07/18/2024 | DOCS | Buy Now | Doximity | $58.09 | -67.29% | Stan Berenshteyn42% | $27 → $19 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 06/20/2024 | HQY | Buy Now | HealthEquity | $86.96 | 26.49% | Stan Berenshteyn42% | $107 → $110 | Maintains | Overweight | Get Alert |
| 06/04/2024 | HQY | Buy Now | HealthEquity | $86.96 | 23.05% | Stan Berenshteyn42% | $105 → $107 | Maintains | Overweight | Get Alert |
| 05/10/2024 | HCAT | Buy Now | Health Catalyst | $4.55 | 185.71% | Stan Berenshteyn42% | $14 → $13 | Maintains | Overweight | Get Alert |
| 04/30/2024 | ACCD | Buy Now | Accolade | $6.99 | 43.06% | Stan Berenshteyn42% | $12 → $10 | Maintains | Equal-Weight | Get Alert |
| 03/25/2024 | GDRX | Buy Now | GoodRx Holdings | $4.41 | 126.7% | Stan Berenshteyn42% | → $10 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/01/2024 | VEEV | Buy Now | Veeva Systems | $234.21 | 3.33% | Stan Berenshteyn42% | $229 → $242 | Maintains | Overweight | Get Alert |
| 03/01/2024 | GDRX | Buy Now | GoodRx Holdings | $4.41 | 70.02% | Stan Berenshteyn42% | $6 → $7.5 | Maintains | Equal-Weight | Get Alert |
| 02/09/2024 | OMCL | Buy Now | Omnicell | $35.01 | -25.74% | Stan Berenshteyn42% | $28 → $26 | Maintains | Equal-Weight | Get Alert |
| 02/09/2024 | DOCS | Buy Now | Doximity | $58.09 | -53.52% | Stan Berenshteyn42% | $25 → $27 | Maintains | Equal-Weight | Get Alert |
| 01/09/2024 | ACCD | Buy Now | Accolade | $6.99 | 71.67% | Stan Berenshteyn42% | $10 → $12 | Maintains | Equal-Weight | Get Alert |
| 12/06/2023 | HQY | Buy Now | HealthEquity | $86.96 | 6.95% | Stan Berenshteyn42% | $89 → $93 | Maintains | Overweight | Get Alert |
| 11/03/2023 | OMCL | Buy Now | Omnicell | $35.01 | -20.02% | Stan Berenshteyn42% | $39 → $28 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/25/2023 | VEEV | Buy Now | Veeva Sys | $234.21 | -2.22% | Stan Berenshteyn42% | $211 → $229 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/11/2023 | ACCD | Buy Now | Accolade | $6.99 | 43.06% | Stan Berenshteyn42% | $14 → $10 | Maintains | Equal-Weight | Get Alert |
| 09/26/2023 | OMCL | Buy Now | Omnicell | $35.01 | 11.4% | Stan Berenshteyn42% | $56 → $39 | Maintains | Underweight | Get Alert |
| 09/05/2023 | VEEV | Buy Now | Veeva Sys | $234.21 | -9.91% | Stan Berenshteyn42% | $180 → $211 | Maintains | Equal-Weight | Get Alert |
| 08/11/2023 | DOCS | Buy Now | Doximity | $58.09 | -56.96% | Stan Berenshteyn42% | $37 → $25 | Maintains | Equal-Weight | Get Alert |
| 08/10/2023 | GDRX | Buy Now | GoodRx Holdings | $4.41 | 58.69% | Stan Berenshteyn42% | $6 → $7 | Maintains | Equal-Weight | Get Alert |
| 07/20/2023 | OMCL | Buy Now | Omnicell | $35.01 | 59.95% | Stan Berenshteyn42% | $65 → $56 | Downgrade | Overweight → Underweight | Get Alert |
| 06/30/2023 | ACCD | Buy Now | Accolade | $6.99 | 100.29% | Stan Berenshteyn42% | $13 → $14 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | DOCS | Buy Now | Doximity | $58.09 | -36.31% | Stan Berenshteyn42% | $39 → $37 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/21/2023 | ACCD | Buy Now | Accolade | $6.99 | 85.98% | Stan Berenshteyn42% | $10 → $13 | Maintains | Equal-Weight | Get Alert |
| 04/04/2023 | HCAT | Buy Now | Health Catalyst | $4.55 | 251.65% | Stan Berenshteyn42% | $13 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/07/2023 | HCAT | Buy Now | Health Catalyst | $4.55 | 185.71% | Stan Berenshteyn42% | $11 → $13 | Maintains | Equal-Weight | Get Alert |
| 03/06/2023 | TDOC | Buy Now | Teladoc Health | $8.09 | 184.3% | Stan Berenshteyn42% | $28 → $23 | Maintains | Equal-Weight | Get Alert |
| 03/02/2023 | GDRX | Buy Now | GoodRx Holdings | $4.41 | 36.02% | Stan Berenshteyn42% | $5.5 → $6 | Maintains | Equal-Weight | Get Alert |
| 02/10/2023 | DOCS | Buy Now | Doximity | $58.09 | -32.86% | Stan Berenshteyn42% | $44 → $39 | Maintains | Overweight | Get Alert |
| 02/03/2023 | HQY | Buy Now | HealthEquity | $86.96 | 2.35% | Stan Berenshteyn42% | $101 → $89 | Maintains | Overweight | Get Alert |
| 01/24/2023 | OMCL | Buy Now | Omnicell | $35.01 | 85.66% | Stan Berenshteyn42% | $71 → $65 | Maintains | Overweight | Get Alert |
| 12/07/2022 | HQY | Buy Now | HealthEquity | $86.96 | 16.15% | Stan Berenshteyn42% | $104 → $101 | Maintains | Overweight | Get Alert |
| 11/11/2022 | DOCS | Buy Now | Doximity | $58.09 | -24.26% | Stan Berenshteyn42% | $38 → $44 | Maintains | Overweight | Get Alert |
| 11/04/2022 | OMCL | Buy Now | Omnicell | $35.01 | 102.8% | Stan Berenshteyn42% | $158 → $71 | Maintains | Overweight | Get Alert |
| 10/31/2022 | VEEV | Buy Now | Veeva Sys | $234.21 | -23.15% | Stan Berenshteyn42% | → $180 | Initiates | → Equal-Weight | Get Alert |
| 10/31/2022 | HCAT | Buy Now | Health Catalyst | $4.55 | 119.78% | Stan Berenshteyn42% | → $10 | Initiates | → Equal-Weight | Get Alert |
| 10/31/2022 | DOCS | Buy Now | Doximity | $58.09 | -34.58% | Stan Berenshteyn42% | → $38 | Initiates | → Overweight | Get Alert |
| 10/25/2022 | HQY | Buy Now | HealthEquity | $86.96 | 19.6% | Stan Berenshteyn42% | $100 → $104 | Maintains | Overweight | Get Alert |
| 10/12/2022 | ACCD | Buy Now | Accolade | $6.99 | 43.06% | Stan Berenshteyn42% | $8 → $10 | Maintains | Equal-Weight | Get Alert |
| 09/13/2022 | HQY | Buy Now | HealthEquity | $86.96 | 15% | Stan Berenshteyn42% | $95 → $100 | Maintains | Overweight | Get Alert |
| 07/05/2022 | ACCD | Buy Now | Accolade | $6.99 | 14.45% | Stan Berenshteyn42% | $6 → $8 | Maintains | Equal-Weight | Get Alert |
| 05/12/2022 | GDRX | Buy Now | GoodRx Holdings | $4.41 | 104.03% | Stan Berenshteyn42% | $20 → $9 | Maintains | Equal-Weight | Get Alert |
| 05/03/2022 | OMCL | Buy Now | Omnicell | $35.01 | 351.3% | Stan Berenshteyn42% | $188 → $158 | Maintains | Overweight | Get Alert |
| 05/02/2022 | ACCD | Buy Now | Accolade | $6.99 | -14.16% | Stan Berenshteyn42% | → $6 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/28/2022 | TDOC | Buy Now | Teladoc Health | $8.09 | 394.44% | Stan Berenshteyn42% | → $40 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/11/2022 | HQY | Buy Now | HealthEquity | $86.96 | 9.25% | Stan Berenshteyn42% | → $95 | Initiates | → Overweight | Get Alert |
| 04/11/2022 | GDRX | Buy Now | GoodRx Holdings | $4.41 | 353.39% | Stan Berenshteyn42% | → $20 | Initiates | → Equal-Weight | Get Alert |
| 04/11/2022 | ACCD | Buy Now | Accolade | $6.99 | 28.76% | Stan Berenshteyn42% | → $9 | Initiates | → Underweight | Get Alert |
| 02/28/2022 | AMWL | Buy Now | American Well | $7.82 | -48.85% | Stan Berenshteyn42% | $120 → $80 | Maintains | Equal-Weight | Get Alert |
| 02/16/2022 | OMCL | Buy Now | Omnicell | $35.01 | 436.99% | Stan Berenshteyn42% | $203 → $188 | Maintains | Overweight | Get Alert |
| 12/06/2021 | OMCL | Buy Now | Omnicell | $35.01 | 479.83% | Stan Berenshteyn42% | → $203 | Initiates | → Overweight | Get Alert |
